Jesús Aibar

Assistant Professor

University of Barcelona

Spain

Research Interests

Explore related searches

Professors in Spain

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Jesús Aibar is an Assistant Professor at Universitat de Barcelona in Spain. His research focuses on topics related to venous thromboembolism and clinical outcomes associated with anticoagulant therapy. He has recently published articles examining modified cornstarch treatments and the implications of age in venous thromboembolism recurrence. His work contributes to advancing understanding in the field of thrombosis and its management.

Articles (19)

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Collaborators (3)

Mónica Loring

Head of service

Servicio Andaluz de Salud

SPAIN

View details

Pablo Demelo-Rodríguez

Universidad Complutense de Madrid

SPAIN

View details

Manuela Exposito

Profesora Sustituta Interina

Universidad de Granada

SPAIN

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Jesús Aibar

Research Interests

Explore related searches

Contact this professor

About

Articles (19)

Modified cornstarch as an effective treatment for insulinoma-induced hypoglycemia: a case report

Modified cornstarch as an effective treatment for insulinoma-induced hypoglycemia: a case report

Clinical outcomes after discontinuing anticoagulant therapy in patients with first unprovoked venous thromboembolism

Venous thromboembolism (VTE) developing after ankle sprain. Comparison with VTE after knee arthroplasty

Venous thromboembolism (VTE) developing after ankle sprain. Comparison with VTE after knee arthroplasty

Comparison of inferior vena cava filter use and outcomes between cancer and non-cancer patients in a tertiary hospital

Comparison of inferior vena cava filter use and outcomes between cancer and non-cancer patients in a tertiary hospital

Inferior Vena Cava Filters: Adherence to Clinical Practice Guidelines Recommendations, Retrieval Rates, and Filter Complications in a Tertiary Hospital

Age over 75 does not increase the risk of recurrent venous thromboembolism: Findings from the RIETE registry

Age over 75 does not increase the risk of recurrent venous thromboembolism: Findings from the RIETE registry

Efficacy and Safety of Tinzaparin in Prophylactic, Intermediate and Therapeutic Doses in Non-Critically Ill Patients Hospitalized with COVID-19: The PROTHROMCOVID Randomized Controlled Trial

Prognostic impact of acute kidney injury in patients with acute pulmonary embolism data from the RIETE registry

Ventilation/perfusion (V/Q) scanning in contemporary patients with pulmonary embolism: utilization rates and predictors of use in a multinational study

Efficacy and Safety of Tinzaparin in Prophylactic, Intermediate and Therapeutic Doses in Non-Critically Ill Patients Hospitalized with COVID-19: The PROTHROMCOVID Randomized Controlled Trial

Timing and characteristics of venous thromboembolism after noncancer surgery

Erratum: Arterial Thrombosis in Patients with Antiphospholipid Syndrome: A Review and Meta-Analysis

Recurrent bleeding and thrombotic events after resumption of oral anticoagulants following gastrointestinal bleeding: communication from the ISTH SSC Subcommittee on Control of Anticoagulation

Recurrent bleeding and thrombotic events after resumption of oral anticoagulants following gastrointestinal bleeding: Communication from the ISTH SSC Subcommittee on Control of Anticoagulation

Anticoagulation strategies and risk of bleeding events in critically ill COVID-19 patients

Collaborators (3)

Mónica Loring

Pablo Demelo-Rodríguez

Manuela Exposito

Make your next move.